Rare sugar l-sorbose exerts antitumor activity by impairing glucose metabolism
The rare sugar L-sorbose is shown to decrease cell viability and increase apoptotic cells in culture and to enhance the effect of tumor chemotherapy in combination with sorafenib in mouse xenograft models.
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Nature Portfolio
2023-03-01
|
| Sarja: | Communications Biology |
| Linkit: | https://doi.org/10.1038/s42003-023-04638-z |